348 related articles for article (PubMed ID: 19404953)
1. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort.
Schanberg LE; Sandborg C; Barnhart HX; Ardoin SP; Yow E; Evans GW; Mieszkalski KL; Ilowite NT; Eberhard A; Levy DM; Kimura Y; von Scheven E; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy D; Klein-Gitelman M; Wallace C; Silver R; Wagner-Weiner L; Higgins GC; Brunner HI; Jung L; Soep JB; Reed A;
Arthritis Rheum; 2009 May; 60(5):1496-507. PubMed ID: 19404953
[TBL] [Abstract][Full Text] [Related]
2. Body mass index and glucocorticoid dose contribute to subclinical atherosclerosis in Korean patients with systemic lupus erythematosus: A prospective 4 year follow-up study.
Jung JY; Kim HA; Lee HY; Suh CH
Int J Rheum Dis; 2019 Aug; 22(8):1410-1418. PubMed ID: 31050219
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus.
Doria A; Shoenfeld Y; Wu R; Gambari PF; Puato M; Ghirardello A; Gilburd B; Corbanese S; Patnaik M; Zampieri S; Peter JB; Favaretto E; Iaccarino L; Sherer Y; Todesco S; Pauletto P
Ann Rheum Dis; 2003 Nov; 62(11):1071-7. PubMed ID: 14583570
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
5. Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus.
Medeiros PBS; Salomão RG; Teixeira SR; Rassi DM; Rodrigues L; Aragon DC; Fassini PG; Ued FV; Tostes RC; Monteiro JP; Ferriani VPL; de Carvalho LM
Pediatr Rheumatol Online J; 2021 Mar; 19(1):35. PubMed ID: 33743717
[TBL] [Abstract][Full Text] [Related]
6. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
Fischer K
Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
[TBL] [Abstract][Full Text] [Related]
7. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.
Ardoin SP; Schanberg LE; Sandborg CI; Barnhart HX; Evans GW; Yow E; Mieszkalski KL; Ilowite NT; Eberhard A; Imundo LF; Kimura Y; Levy D; von Scheven E; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy DK; Klein-Gitelman M; Wallace C; Silver RM; Wagner-Weiner L; Higgins GC; Brunner HI; Jung L; Soep JB; Reed AM; Thompson SD;
Ann Rheum Dis; 2014 Mar; 73(3):557-66. PubMed ID: 23436914
[TBL] [Abstract][Full Text] [Related]
8. Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients.
Ajeganova S; Gustafsson T; Lindberg L; Hafström I; Frostegård J
Lupus Sci Med; 2020; 7(1):e000362. PubMed ID: 32095248
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Atherosclerosis in Sle Patients by Measuring Carotid Intima Media Thickness: A Cross Sectional Study.
Mukherjee R; Bhattacharya R; Naiya SB; Mondal SS; Lyngdoh L
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443433
[TBL] [Abstract][Full Text] [Related]
10. Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus.
Carbone F; Dallegri F; Montecucco F; Poggi A; Nobili FM; Cacciapaglia F; Afeltra A; Moccetti T; Colombo BM
Eur J Clin Invest; 2019 May; 49(5):e13089. PubMed ID: 30767212
[TBL] [Abstract][Full Text] [Related]
11. Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus.
Falaschi F; Ravelli A; Martignoni A; Migliavacca D; Sartori M; Pistorio A; Perani G; Martini A
Arthritis Rheum; 2000 Jun; 43(6):1405-9. PubMed ID: 10857801
[TBL] [Abstract][Full Text] [Related]
12. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis.
Wu GC; Liu HR; Leng RX; Li XP; Li XM; Pan HF; Ye DQ
Autoimmun Rev; 2016 Jan; 15(1):22-37. PubMed ID: 26455562
[TBL] [Abstract][Full Text] [Related]
13. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
[TBL] [Abstract][Full Text] [Related]
14. Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting.
Telles RW; Lanna CC; Ferreira GA; Souza AJ; Navarro TP; Ribeiro AL
Lupus; 2008 Feb; 17(2):105-13. PubMed ID: 18250133
[TBL] [Abstract][Full Text] [Related]
15. Carotid intima-media thickness and arterial stiffness in pediatric systemic lupus erythematosus.
Su-Angka N; Khositseth A; Vilaiyuk S; Tangnararatchakit K; Prangwatanagul W
Lupus; 2017 Aug; 26(9):989-995. PubMed ID: 28420050
[TBL] [Abstract][Full Text] [Related]
16. Predictors of thickened carotid intima media thickness among well controlled lupus nephritis patients in a Malaysian tertiary centre.
Shaharir SS; Mohamed Said MS; Kong NC
Reumatismo; 2012 Dec; 64(6):341-9. PubMed ID: 23285477
[TBL] [Abstract][Full Text] [Related]
17. Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus.
Wirestam L; Saleh M; Svensson C; Compagno M; Zachrisson H; Wetterö J; Sjöwall C
Lupus; 2021 Jul; 30(8):1244-1253. PubMed ID: 33957796
[TBL] [Abstract][Full Text] [Related]
18. Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study.
Rua-Figueroa I; Arencibia-Mireles O; Elvira M; Erausquin C; Ojeda S; Francisco F; Naranjo A; Rodríguez-Gallego C; Garcia-Laorden I; Rodríguez-Perez J; Rodríguez-Lozano C
Ann Rheum Dis; 2010 Jun; 69(6):1136-9. PubMed ID: 19687018
[TBL] [Abstract][Full Text] [Related]
19. Use of atorvastatin in systemic lupus erythematosus in children and adolescents.
Schanberg LE; Sandborg C; Barnhart HX; Ardoin SP; Yow E; Evans GW; Mieszkalski KL; Ilowite NT; Eberhard A; Imundo LF; Kimura Y; von Scheven E; Silverman E; Bowyer SL; Punaro M; Singer NG; Sherry DD; McCurdy D; Klein-Gitelman M; Wallace C; Silver R; Wagner-Weiner L; Higgins GC; Brunner HI; Jung L; Soep JB; Reed AM; Provenzale J; Thompson SD;
Arthritis Rheum; 2012 Jan; 64(1):285-96. PubMed ID: 22031171
[TBL] [Abstract][Full Text] [Related]
20. Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus.
Huang YL; Chung HT; Chang CJ; Yeh KW; Chen LC; Huang JL
Arthritis Rheum; 2009 Dec; 60(12):3766-75. PubMed ID: 19950269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
